Skip to main content
Michael Blaha, MD, Cardiology, Baltimore, MD

MichaelJosephBlahaMDMPH

Cardiology • Baltimore, MD

Non-Invasive Cardiology, Preventive Cardiology

Professor of Medicine and Epidemiology, Johns Hopkins University School of Medicine; Director of Clinical Research, Ciccarone Center for the Prevention of Cardiovascular Disease

Join to view full profile

Dr. Blaha is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Blaha's full profile

Already have an account?

  • Office

    600 N Wolfe St
    Carnegie 565 Johns Hopkins Hospital
    Baltimore, MD 21287
    Phone+1 410-955-5000
    Fax+1 410-367-2448

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2009 - 2012
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2006

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2011 - 2026

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Sociodemographic Disparities in Influenza Vaccination Among Adults with Atherosclerotic Cardiovascular Disease in the United States  
    Ron Blankstein, Michael J Blaha, Salim S Virani, Khurram Nasir, JAMA Cardiology
  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk Factors  
    Seamus P Whelton, John W Mcevoy, Matthew Budoff, Khurram Nasir, Roger S Blumenthal, Michael J Blaha, JAMA Cardiology
  • Review Article Communication Issues in Nutritional Observational Research  
    Michael J Blaha, Roger S Blumenthal, John W McEvoy, ScienceDirect
  • Join now to see all

Lectures

  • Debate Pro: No Contest! Calcium Scoring Beats Risk Scores and Should be More Broadly Performed 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Authored Content

  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
  • Association of Normal Systolic Blood Pressure Level with Cardiovascular Disease in the Absence of Risk FactorsJune 2020
  • Coronary Artery Calcium: Recommendations for Risk Assessment in Cardiovascular Prevention GuidelinesSeptember 2018
  • Impact of C-reactive Protein and Coronary Artery Calcium on Benefit Observed with AtorvastatinMay 2018
  • Impact of C-reactive Protein and Coronary Artery Calcium on Benefit Observed with AtorvastatinMay 2018
  • The Prognostic Value of High Sensitivity C-reactive Protein in a Multi-Ethnic Population After >10 Years of Follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA)May 2018
  • The Prognostic Value of High Sensitivity C-reactive Protein in a Multi-Ethnic Population After >10 Years of Follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA)May 2018
  • Circulating Interleukin-6 Is a Biomarker for Coronary Atherosclerosis in Nonalcoholic Fatty Liver Disease: Results from the Multi-Ethnic Study of AtherosclerosisMarch 2018
  • 10-Year Resource Utilization and Costs for Cardiovascular CareMarch 2018
  • Join now to see all

Press Mentions

  • Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key
    Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is KeyNovember 13th, 2024
  • Highlights from the 19th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography in 2024
    Highlights from the 19th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography in 2024November 5th, 2024
  • Omecamtiv Mecarbil Not Ready for Prime Time, FDA Advisors Say
    Omecamtiv Mecarbil Not Ready for Prime Time, FDA Advisors SayDecember 13th, 2022
  • Join now to see all

Professional Memberships

External Links

Dr. Michael Blaha, Dr. Michael Blaha, MD, Dr. M Blaha, Dr. Michael Joseph Blaha